|Last Price$12.42||Day Change (%)0.16%|
|Open Price$12.42||Day Change ($)0.02|
|Day Range12.42–12.42||52-Week Range12.19–12.80|
As of Mon 03/27/2017 | USD
Global Epinephrine Autoinjector Market to Grow at a CAGR of 14.58%, 2017-2021 with ALK-Abell, Impax Laboratories, Lincoln Medical & Mylan Dominating - Research and Markets
Despite the high 39% premium to Hospira's stock price, we believe the acquisition price is justified based on Pfizer's ability to unlock more value with its global reach.
Welcome to Hospira's First Quarter 2014 Conference Call. All lines have been placed on listen-only mode to prevent any background noise. Following the speakers' remarks, there will be a question-and-answer period.
ICU Medical's 2017 Guidance Misses Expectations -- Update
Global Market to Reach 17.2 Billion by 2021 - Focus on Recent Patents Related To Polymers And Medical Devices - Research and Markets